by clearskymd | Nov 16, 2020 | Company News
ClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of Parkinson’s. Statins, such as Simvastatin, are a group of medicines that are currently prescribed to lower cholesterol in the blood....
by clearskymd | Sep 24, 2020 | Company News
ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology. Data science company StartUs Insights, which identifies startups, disruptive technologies and new business models early-on, selected...
by clearskymd | Jul 7, 2020 | Company News
We have launched a new study in China to establish introducing bradykinesia as a feature being measured by LID-Monitor. Parkinson’s is the second most common neurodegenerative disorder and is characterised by bradykinesia – a slowness in carrying out movements....
by clearskymd | Feb 6, 2020 | Blog
We were delighted to be invited to showcase our technology and devices at a prestigious innovation exchange event in Leeds in January – MIT Reap. The event was part of an international programme that the city of Leeds was chosen to host, in partnership with one...
by clearskymd | Oct 31, 2019 | Parkinson's
Levodopa is one of the main medications used to treat symptoms of Parkinson’s. As Parkinson’s progresses the doses of levodopa needed to maintain control over symptoms increases. Dyskinesia is a complication of long-term levodopa use in people who have had...
Recent Comments